Evidence map›Paper›PMID 39203048›Full record

ArticleMolecules (Basel, Switzerland)2024

Visible-Light-Induced Diselenide-Crosslinked Polymeric Micelles for ROS-Triggered Drug Delivery.

Xinfeng Cheng, Huixian Li, Xiaomeng Sun, Tianxu Xu, Zhenzhen Guo, Xianchao Du, Shuai Li, Xuyang Li, Xiaojing Xing, Dongfang Qiu

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Xinfeng ChengCollege of Chemistry and Pharmaceutical Engineering, Nanyang Normal University, Nanyang 473061, China.ORCID 0009-0007-0586-9687
Huixian LiCollege of Chemistry and Pharmaceutical Engineering, Nanyang Normal University, Nanyang 473061, China.
Xiaomeng SunCollege of Chemistry and Pharmaceutical Engineering, Nanyang Normal University, Nanyang 473061, China.
Tianxu XuCollege of Chemistry and Pharmaceutical Engineering, Nanyang Normal University, Nanyang 473061, China.
Zhenzhen GuoCollege of Chemistry and Pharmaceutical Engineering, Nanyang Normal University, Nanyang 473061, China.
Xianchao DuCollege of Chemistry and Pharmaceutical Engineering, Nanyang Normal University, Nanyang 473061, China.
Shuai LiCollege of Chemistry and Pharmaceutical Engineering, Nanyang Normal University, Nanyang 473061, China.
Xuyang LiCollege of Chemistry and Pharmaceutical Engineering, Nanyang Normal University, Nanyang 473061, China.
Xiaojing XingCollege of Chemistry and Pharmaceutical Engineering, Nanyang Normal University, Nanyang 473061, China.
Dongfang QiuCollege of Chemistry and Pharmaceutical Engineering, Nanyang Normal University, Nanyang 473061, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

To synthesize an effective and versatile nano-platform serving as a promising carrier for controlled drug delivery, visible-light-induced diselenide-crosslinked polyurethane micelles were designed and prepared for ROS-triggered on-demand doxorubicin (DOX) release. A rationally designed amphiphilic block copolymer, poly(ethylene glycol)-

Indexed as

DoxorubicinLightMicellesPolymersReactive Oxygen SpeciesCell SurvivalDrug CarriersDrug Delivery SystemsDrug LiberationHeLa CellsHumansParticle SizePolyethylene GlycolsDoxorubicinDrug CarriersMicellesPolyethylene GlycolsPolymersReactive Oxygen Speciescrosslinkingdiselenidedrug deliveryROS responsivenessvisible-light sensitivity

Identifiers

PMID39203048
PMCPMC11357037

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.